HCG22 and lip and oral cavity carcinoma: Importantly, these results provided us with important information regarding the diagnostic and prognostic role of lncRNAs in oral cancer and pointed out lncRNA HCG22 as a candidate prognosis biomarker or potential therapeutic target.